-
摘要: 目的：探讨成人肾上腺皮质癌（ACC）的诊断及治疗方法。方法：对1986年~2012年期间我科收治的25例成人肾上腺皮质癌患者的临床资料进行回顾性分析，结合文献就其临床表现、影像学特征、诊断及鉴别诊断、治疗等问题进行讨论。本组25例术前均行B超、IVP、CT、MRI等影像检查。结果：14例行手术治疗并经术后病理证实。术后平均生存10.2个月，3年生存率为14.3%（2/14），5年生存率为0。结论：肾上腺皮质癌恶性程度高、浸润性强，早期诊断和治疗是改善预后的关键，手术根治性切除仍是目前治疗的最佳方法。Abstract: Objective: To study the diagnosis and treatment of adrenocortical carcinoma (ACC) in adults.Method: Twenty-five cases of adrenocortical carcinoma in adults from 1986 to 2012 were retrospectively studied. The clinical features, laboratory data, imaging findings, diagnosis and differential diagnosis were discussed. Radiologic evaluation were performed in all cases, including ultrasound, CT, MRI and IVP.Result: Fourteen cases treated with surgery and were confirmed pathologically. The mean survival duration was 10.2 months, The three-year and five-year survival rate was 14.3% (2/14) and 0 (0/14) respectively.Conclusion: Adrenocortical carcinoma is an aggressive and lethal malignancy. The key to improving prognosis depends on early diagnosis and treatment. Radical resection is still the best choice for the patients.
-
Key words:
- adrenocortical carcinoma /
- diagnosis /
- treatment
-
-
[1] Allolio B, Hahner S, Weismann D, et al. Management of adrenocortical carcinoma[J]. Clin Endocrinol (Oxf), 2004, 60(3):273-287.
[2] Fulmer B R. Diagnosis and management of adrenal cortical carcinoma[J]. Curr Urol Rep, 2007, 8(1):77-82.
[3] Schulick R D, Brennan M F. Adrenocortical carcinoma[J]. World J Urol, 1999, 17(1):26-34.
[4] Schulick R D, Brennan M F. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma[J]. Ann Surg Oncol, 1999, 6(8):719-726.
[5] Bilimoria K Y, Shen W T, Elaraj D, et al. Adrenocortical carcinoma in the United States:treatment utilization and prognostic factors[J]. Cancer, 2008, 113(11):3130-3136.
[6] Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma[J]. Best Pract Res Clin Endocrinol Metab, 2009, 23(2):273-289.
[7] 杨长海, 强万明. 功能性肾上腺皮质癌的诊断和治疗[J]. 临床泌尿外科杂志, 2000, 15(5):211-212.
[8] Lebastchi A H, Kunstman J W, Carling T. Adrenocortical carcinoma:current therapeutic state-of-the-art[J]. J Oncol, 2012:234726.
[9] 沈文, 胡卫列. 细胞衰老与肾上腺肿瘤[J]. 实用医学杂志, 2006,22 (23):2819-2820.
[10] Grumbach M M, Biller B M, Braunstein G D, et al. Management of the clinically inapparent adrenal mass ("incidentaloma")[J]. Ann Intern Med, 2003, 138(5):424-429.
[11] Yip L, Tublin M E, Falcone J A, et al. The adrenal mass:correlation of histopathology with imaging[J]. Ann Surg Oncol, 2010, 17(3):846-852.
[12] Slattery J M, Blake M A, Kalra M K, et al. Adrenocortical carcinoma:contrast washout characteristics on CT[J]. AJR Am J Roentgenol, 2006, 187(1):W21-W24.
[13] Szolar D H, Korobkin M, Reittner P, et al. Adrenocortical carcinomas and adrenal pheochromocytomas:mass and enhancement loss evaluation at delayed contrast-enhanced CT[J]. Radiology, 2005, 234(2):479-485.
[14] Tucci S J, Martins A C, Suaid H J, et al. The impact of tumor stage on prognosis in children with adrenocortical carcinoma[J]. J Urol, 2005, 174(6):2338-2342, 2342.
[15] Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas:surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group[J]. World J Surg, 2001, 25(7):891-897.
[16] Lee J E, Berger D H, El-Naggar A K, et al. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma[J]. Surgery, 1995, 118(6):1090-1098.
[17] Hermsen I G, Kerkhofs T M, den Butter G, et al. Surgery in adrenocortical carcinoma:Importance of national cooperation and centralized surgery[J]. Surgery, 2012, 152(1):50-56.
[18] Johanssen S, Hahner S, Saeger W, et al. Deficits in the management of patients with adrenocortical carcinoma in Germany[J]. Dtsch Arztebl Int, 2010, 107(50):885-891.
[19] 刘珍才,费翔. 肾上腺皮质癌的诊断与治疗(附19例报告)[J]. 河北医学,2005, 11(1):62-64.
-
计量
- 文章访问数: 277
- PDF下载数: 129
- 施引文献: 0
下载: